EP 0470144 A1 19920212 - BETA-HYDROXAMATE D-ASPARTIC ACID FOR TREATMENT OF VIRAL INFECTIONS AND TUMOURS.
Title (en)
BETA-HYDROXAMATE D-ASPARTIC ACID FOR TREATMENT OF VIRAL INFECTIONS AND TUMOURS.
Title (de)
D-ASPARAGINSÄURE-BETA-HYDROXAMAT ZUR BEHANDLUNG VIRALER INFEKTIONEN UND TUMOREN.
Title (fr)
D-ACIDE ASPARTIQUE BETA-HYDROXAMATE POUR LE TRAITEMENT DES INFECTIONS VIRALES ET DES TUMEURS.
Publication
Application
Priority
- FR 9000307 W 19900427
- FR 8905744 A 19890428
Abstract (en)
[origin: WO9013291A1] Beta-hydroxamate D-aspartic acid as a medicine, in particular for treating infections diseases caused by retroviruses, especially those that cause AIDS, as well as for treating tumours.
Abstract (fr)
D-acide aspartique beta-hydroxamate en tant que médicament, en particulier pour le traitement des maladies infectieuses dues aux rétrovirus, notamment ceux responsables du SIDA, ainsi que pour le traitement des tumeurs.
IPC 1-7
IPC 8 full level
A61K 9/14 (2006.01); A61K 31/195 (2006.01); A61K 38/50 (2006.01); A61P 31/12 (2006.01); A61P 31/18 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP)
A61K 31/195 (2013.01); A61K 38/50 (2013.01); A61P 31/12 (2017.12); A61P 31/18 (2017.12); A61P 35/00 (2017.12)
Citation (search report)
See references of WO 9013291A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB IT LI LU NL SE
DOCDB simple family (publication)
WO 9013291 A1 19901115; AT E121935 T1 19950515; AU 5657590 A 19901129; AU 660916 B2 19950713; CA 2050936 A1 19901029; DE 69019148 D1 19950608; DE 69019148 T2 19950831; DK 0470144 T3 19951002; EP 0470144 A1 19920212; EP 0470144 B1 19950503; ES 2072431 T3 19950716; FR 2646348 A1 19901102; FR 2646348 B1 19940422; JP H04506796 A 19921126; OA 09519 A 19921115
DOCDB simple family (application)
FR 9000307 W 19900427; AT 90907159 T 19900427; AU 5657590 A 19900427; CA 2050936 A 19900427; DE 69019148 T 19900427; DK 90907159 T 19900427; EP 90907159 A 19900427; ES 90907159 T 19900427; FR 8905744 A 19890428; JP 50739290 A 19900427; OA 60087 A 19911025